Discover
TDOC
Teladoc Health, Inc.
6.30
3100 x 6.22
3500 x 6.23
bid
ask
+
0.02
0.32%
3300 @ 07:30 PM
6.22 -0.08 (1.20%)
| Ytd | -10.00% | |
| 1y | -23.73% |
6.18
day range
6.34
4.47
52 week range
9.72
| Open | 6.31 | Prev Close | 6.28 | Low | 6.18 | High | 6.34 | Mkt Cap | 1.14B |
| Vol | 5.50M | Avg Vol | 4.54M | EPS | -0.99 | P/E | N/A | Forward P/E | -8.03 |
| Beta | 2.13 | Short Ratio | 5.88 | Inst. Own | 86.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-28 | 50-d Avg | 7.35 | 200-d Avg | 6.65 | 1yr Est | 7.67 |
| Income Statement | |||
| Total Revenue | 606.93M | ||
| Revenues (USD) | 606.93M | ||
| Cost of Revenue | 190.84M | ||
| Gross Profit | 416.09M | ||
| Operating Expenses | 453.18M | ||
| Research and Development Expense | 62.86M | ||
| Selling, General and Administrative Expense | 296.82M | ||
| Operating Income | -37.09M | ||
| Interest Expense | 5.11M | ||
| Income Tax Expense | 997.00K | ||
| Net Income | -38.91M | ||
| Net Income Common Stock | -38.91M | ||
| Net Income Common Stock (USD) | -38.91M | ||
| Consolidated Income | -38.91M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -32.80M | ||
| Earning Before Interest & Taxes (USD) | -32.80M | ||
| Weighted Average Shares | 181.03M | ||
| Weighted Average Shares Diluted | 181.03M | ||
| Balance Sheet | |||
| Cash and Equivalents | 774.35M | ||
| Cash and Equivalents (USD) | 774.35M | ||
| Trade and Non-Trade Receivables | 221.02M | ||
| Current Assets | 1.15B | ||
| Property, Plant & Equipment Net | 47.41M | ||
| Total Assets | 2.76B | ||
| Debt Current | 996.70M | ||
| Total Debt | 1.03B | ||
| Current Liabilities | 1.38B | ||
| Debt Non-Current | 29.54M | ||
| Total Liabilities | 1.45B | ||
| Accumulated Retained Earnings (Deficit) | -16.53B | ||
| Accumulated Other Comprehensive Income | -33.93M | ||
| Shareholders Equity | 1.31B | ||
| Shareholders Equity (USD) | 1.31B | ||
| Assets Non-Current | 1.61B | ||
| Total Debt (USD) | 1.03B | ||
| Deferred Revenue | 70.48M | ||
| Goodwill and Intangible Assets | 1.46B | ||
| Inventory | 28.82M | ||
| Liabilities Non-Current | 66.79M | ||
| Trade and Non-Trade Payables | 37.50M | ||
| Tax Liabilities | 26.88M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 92.41M | ||
| Net Cash Flow from Financing | 875.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 23.95M | ||
| Capital Expenditure | -28.92M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -12.67M | ||
| Issuance (Purchase) of Equity Shares | 875.00K | ||
| Net Cash Flow from Investing | -41.59M | ||
| Net Cash Flow from Operations | 64.66M | ||
| Effect of Exchange Rate Changes on Cash | -337.00K | ||
| Share Based Compensation | 9.30M | ||